固定剂量组合的阿皮克萨班和克洛皮多格雷尔:配方和体外评估
Ni'meh Al-Shami1, Hani Naseef1, Feras Kanaze1
1Pharmacy Department, Faculty of Pharmacy, Nursing, and Health Professions, Birzeit University, State of Palestine, PO Box, 14, Palestine.
概括
这项研究开发了一种含有阿皮克萨班和克洛皮多格雷尔的固定剂量组合药片,用于预防血栓形成. 优化的配方提供24小时延长释放的阿皮克萨班和立即释放的克洛皮多格雷尔.
科学领域:
- 制药科学 制药科学
- 药物输送系统 药物输送系统
- 心血管药理学心血管药理学
背景情况:
- 固定剂量组合 (FDC) 产品提供了一种安全且具有成本效益的药物治疗方法.
- 同时使用抗凝剂和抗血小板剂在心血管患者中很普遍.
研究的目的:
- 为制造含有阿皮克萨班和克洛皮多格雷尔的固定剂量组合 (FDC) 片.
- 开发延长释放的阿皮克萨班和立即释放的克洛皮多格勒用于血栓栓塞事件预防和治疗.
主要方法:
- 阿皮克萨班延长释放片使用设计专家软件和各种聚合物制成.
- 克洛皮多格雷尔即时释放片是使用不同的稀释剂开发的.
- 两种配方均经过直接压缩和湿颗粒处理,随后进行溶解分析和封装.
主要成果:
- 阿皮克萨班的释放遵循零级动力学,主要由超级案例II运输控制.
- 聚合物类型和度显著影响了阿皮克萨班释放率 (P < 0.05),HPMC减缓释放的增加.
- 优化的克洛皮多格雷尔片与喷雾干燥的乳糖和乙醇烟酸盐表现出良好的稳定性和性能.
结论:
- 实现了最佳的FDC配方,提供24小时延长释放的阿皮克萨班和立即释放的克洛皮多格雷尔.
- 该研究表明,成功开发了一种双重作用药片,用于控制血栓栓塞风险.
相关概念视频
Dosage Regimen: Fixed Dose
1.9K
Fixed-dose regimens are a common approach to administer drugs to achieve and maintain desired levels of the drug in the body. In this dosing strategy, a specific amount of medication is given at regular intervals, often multiple times a day, to ensure a consistent drug concentration in the bloodstream.
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
1.9K
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
521
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
521
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.2K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.2K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
686
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
686
Factors Influencing Drug Absorption: Pharmaceutical Parameters
133
Solid dosage forms such as tablets and capsules undergo rigorous manufacturing processes to ensure stability and effectiveness. Their dissolution and absorption properties are influenced significantly by the choice of excipients (inactive ingredients that serve various roles in the formulation), and the methodology applied during production. The manufacturing parameters, such as compression force and granulation techniques, significantly affect dissolution rates. Elevated compression forces...
133
Preclinical Development: Overview
4.4K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.4K


